Note 3 - Balance Sheet Components

6 Months Ended

Jun. 30, 2024

Notes to Financial Statements

Supplemental Balance Sheet Disclosures [Text Block]

3. Balance Sheet Components

Prepaid Expenses – Prepaid expenses consist of the following:

	June 30, 2024		December 31, 2023
Prepaid clinical trial costs (current portion)	$	1,921,190	$	1,282,746
Prepaid insurance premiums		36,899		110,695
Prepaid rent		13,045		13,045
Other prepaid expenses		10,000		26,667
Total prepaid expenses	$	1,981,134	$	1,433,153

Property and Equipment – Property and equipment consist of the following:

	June 30, 2024			December 31, 2023
Equipment and furnishings	$	774,758		$	774,758
Leasehold improvements		115,605			115,605
Total property and equipment		890,363			890,363
Accumulated depreciation and amortization		(719,826	)		(680,674	)
Total property and equipment, net	$	170,537		$	209,689

Other Assets – Other assets consist of the following:

	June 30, 2024		December 31, 2023
Prepaid clinical trial costs (noncurrent portion)	$	-	$	1,106,778
Prepaid technology license fees		70,000		70,000
Deposits		11,010		11,010
Total other assets	$	81,010	$	1,187,788

Accrued Expenses – Accrued expenses consist of the following:

	June 30, 2024		December 31, 2023
Payroll-related liabilities	$	168,974	$	114,337
Accrued clinical trial costs		351,460		490,635
Accrued contract manufacturing costs		1,687,874		-
Other accrued expenses		70,000		111,959
Total accrued expenses	$	2,278,308	$	716,931